AMGN compared with SLDB: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

SLDBSolid Biosciences Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

SLDBSolid Biosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

478.34· pre 478.02· delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

SLDBSolid Biosciences Inc.

6.51· pre 5.64· delayed

Pre-marketNov 5 '26delayed

Mkt cap$673.4MRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

AMGNAmgen Inc

SLDBSolid Biosciences Inc.

478.34pre 478.02delayed

Price

6.51pre 5.64delayed

$258.8B

Mkt cap

$673.4M

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN478.34vsSLDB6.51Pre-marketNov 5 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SLDB: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only SLDB 7

—FA212unlistedsupplier

—ICS Maugeriunlistedsupplier

—University of Pennsylvaniaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

University of Washington

unlistedsupplier

3 more · SLDB chain ›

Price

rebased to 0%

AMGN, solidSLDB, dashed